| 222 |
Mental stress to agitation |
Lyle Burgoon |
Open for adoption |
1396: Increased, glucocorticoid receptor activity
|
1345: Increased, agitation
|
|
|
| 221 |
Mental stress to depression |
Lyle Burgoon |
Open for adoption |
1396: Increased, glucocorticoid receptor activity
|
1346: Increased, depression
|
|
|
| 217 |
Gastric ulcer formation |
Lyle Burgoon |
Open for adoption |
None
|
2 AOs
|
|
|
| 214 |
Network of SSRIs (selective serotonin reuptake inhibitors) |
Lyle Burgoon |
Open for adoption |
None
|
4 AOs
|
|
|
| 213 |
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH) |
Lyle Burgoon |
Open for adoption |
1490: Inhibition, Fatty Acid Beta Oxidation
|
1489: Increase, Steatohepatitis
|
|
|
| 577 |
AhR activation leading to endometriosis |
Léna CAUDAL |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 470 |
Deposition of energy leads to abnormal vascular remodeling |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2069: Occurrence, Abnormal Vascular Remodeling
|
WPHA/WNT Endorsed |
1.89 |
| 483 |
Deposition of Energy Leading to Learning and Memory Impairment |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.89 |
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 478 |
Deposition of energy leading to occurrence of cataracts |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2083: Occurrence of Cataracts
|
WPHA/WNT Endorsed |
1.89 |
| 272 |
Deposition of energy leading to lung cancer |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
1556: Increase, lung cancer
|
WPHA/WNT Endorsed |
1.56 |
| 515 |
An overview of adverse outcome pathway linked between PM2.5 exposure and congenital heart defects |
Liang Chen |
BY-SA |
None
|
None
|
|
|
| 206 |
Peroxisome proliferator-activated receptors γ inactivation leading to lung fibrosis |
Jinhee Choi |
BY-SA |
1270: Inactivation of PPARγ
|
1276: Lung fibrosis
|
Under Development |
1.54 |
| 210 |
Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building |
Jinhee Choi |
BY-SA |
None
|
1277: Reproductive failure
|
|
|
| 209 |
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP |
Jinhee Choi |
BY-SA |
None
|
1291: Hepatotoxicity
|
|
|
| 208 |
Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure |
Jinhee Choi |
BY-SA |
None
|
1277: Reproductive failure
|
|
|
| 207 |
NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans |
Jinhee Choi |
BY-SA |
1174: Activation, NADPH Oxidase
|
1277: Reproductive failure
|
|
|
| 512 |
Reduced availability of GnRH leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Ana-Andreea Cioca |
BY-SA |
None
|
None
|
|
|
| 530 |
Endocytotic lysosomal uptake leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1539: Endocytotic lysosomal uptake
|
1931: Intestinal barrier, disruption
|
|
|
| 468 |
Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death) |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 422 |
Binding of SARS-CoV-2 to ACE2 in enterocytes leads to intestinal barrier disruption |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 428 |
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
None
|
Under Development |
1.96 |
| 394 |
SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia) |
Sandra Coecke |
BY-SA |
1739: Binding to ACE2
|
1873: impaired olfactory function (anosmia)
|
Under Development |
1.96 |
| 334 |
Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration |
Alexander Cole |
BY-SA |
122: Increase, Glucocorticoid receptor activation
|
360: Decrease, Population growth rate
|
|
|
| 288 |
Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals) |
Bérénice COLLET |
BY-SA |
1609: Inhibition, Cytochrome P450 enzyme (CYP17A1) activity
|
1616: Malformation, cryptorchidism - maldescended testis
|
|
|